Michael T Sapko
5PUBLICATIONS
2CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Dec 23, 2024
Quality Assurance of Depression Ratings in Psychiatric Clinical Trials.Michael T Sapko, Cortney Kolesar, Ian R Sharp
|Apr 26, 2024
NRX-101 (D-Cycloserine + Lurasidone) Is Active against Drug-Resistant Urinary Pathogens In Vitro.Michael T Sapko, Michael Manyak, Riccardo Panicucci
|Aug 09, 2023
Correction to: Diagnosis and Management of Hepatitis Delta Virus Infection.Calvin Pan, Robert Gish, Ira M Jacobson
|Jun 20, 2023
Diagnosis and Management of Hepatitis Delta Virus Infection.Calvin Pan, Robert Gish, Ira M Jacobson
|May 24, 2023
NRX-101, a Rapid-Acting Anti-Depressant, Does Not Cause Neurotoxicity Following Ketamine Administration in Preclinical Models.William Jordan, Michael T Sapko, Richard Siegel
Pageof 1
